Table 1.
Median age at sarcoma diagnosis, years [IC 95%] | 48 [0–83] |
Median age at locally advanced/metastatic diagnosis, years [IC 95%] | 50 [5–83] |
Median age at inclusion, years [IC 95%] | 51.3 [6.8–84.6] |
Sex: | |
Female | 85 (58%) |
Male | 73 (42%) |
Performance status: | |
0 | 46 (29%) |
1 | 74 (47%) |
2 | 19 (12%) |
3 | 5 (3%) |
NA | 14 (9%) |
Tumor location: | |
Trunk | 39 (25%) |
Intra-abdominal | 68 (43%) |
Limbs | 51 (32%) |
Genomic profile: | |
Single driver genomic alteration | 57 (36%) |
Complex genomic profile | 101 (64%) |
Median OS after metastatic diagnosis, years [IC 95%] | 4.34 [3.73–5.15] |